Chemomab Therapeutics Ltd (CMMB) Quarterly Balance Sheets

Quarterly · GAAP · USD millions
Access CMMB Annual Balance Sheets →
Looking at balance sheet data from Chemomab Therapeutics Ltd through Dec 31 2024 provides insight into Dec 31 2025's solvency and capital structure over time.
Quarterly Report, GAAP in USD millions
ITEM
(Dec 31 2025)
0 0 0 (Dec 31 2024)
Assets
Cash & cash equivalent7.56
Deposits Assets, Current AS2.80
Cash & Short-term Investments9.00
Other Current Assets0.00
Prepaid Expense And Other Assets Current3.06
Total Current Assets13.43
Equipment/Property/Plant Net0.31
Long-term investments0.00
Tax Assets, Noncurrent3.27
Prepaid Expense, Noncurrent, Total PR0.21
Total Assets13.81
Liabilities
Accounts Payable, Trade, Current0.49
Accrued Liabilities, Current0.34
Taxes Payable0.00
Total Current Liabilities1.48
Total Long-term Debt0.00
Other liabilities, Noncurrent0.66
Total Liabilities1.48
Stockholders' Equity
Additional Paid In Capital Common Stock123.95
Retained Earnings / Accumulated Deficit-111.62
Other Equity0.00
Common Stockholder's Equity12.33
Total Stockholder's Equity12.33
Liabilities & Stockholder's Equity13.81
4 historic quarters locked

Sign in to unlock the full Chemomab Therapeutics Ltd balance sheet history.

About Chemomab Therapeutics Ltd Quarterly Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 20-F filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

  • Form: 20-F (Period: 20251231)
  • Filed with the SEC: March 23, 2026
  • Source: zk2634510.htm

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001178913-26-001593

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.